CN104069283A - Traditional Chinese medicine for treating hepatitis - Google Patents
Traditional Chinese medicine for treating hepatitis Download PDFInfo
- Publication number
- CN104069283A CN104069283A CN201310099127.9A CN201310099127A CN104069283A CN 104069283 A CN104069283 A CN 104069283A CN 201310099127 A CN201310099127 A CN 201310099127A CN 104069283 A CN104069283 A CN 104069283A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- herba
- hepatitis
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating hepatitis. The traditional Chinese medicine is prepared from following raw materials by weight, 3-15 parts of dried orange peel, 20-40 parts of oriental wormwood, 5-20 parts of red sage root, 2-7 parts of mint, 2-10 parts of akebia stem, 2-7 parts of coptis, 5-15 parts of rheum officinale, 5-15 parts of cape jasmine fruit, 5-15 parts of rhizoma alismatis, 2-10 parts of balloonflower root, 20-40 parts of herba houttuyniae, 2-10 parts of aucklandia root, 20-40 parts of herba patriniae, 20-40 parts of clematis root, 20-40 parts of herb of christina loosestrife, 20-40 parts of isatis root, 20-40 parts of gentian root, 20-40 parts of plantain herb and 15-35 parts of Chinese date. The medicine can be used for treating icteric hepatitis and viral hepatitis, and has obvious effects on abnormality of indexes such as bilirubin, transaminase, two pairs of semi-hepatitis, and DNA which are caused by hepatitis.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine for the treatment of hepatitis.
Background technology
Hepatitis is the inflammation of liver, the reason of hepatitis may be different, modal is that virus causes, in addition also have autoimmune to cause, excessive drinking also can cause hepatitis, conventionally said hepatitis in our life, majority refers to the viral hepatitis being caused by hepatitis viruss such as A type, B-mode, the third type, fourth type, penta types.Sometimes human nutrition is bad, tired, and an even slight cat fever, all likely causes the impaired of liver function.Hepatitis is as a kind of frequently-occurring spreading disease, our healthy and daily life of serious threat, and the current domestic medicine that has a lot for the treatment of hepatitis, but in Chinese medicine, the treatment works well seldom, can not meet people's demand.
Summary of the invention
Problem to be solved by this invention is to provide a kind of Chinese medicine for the treatment of hepatitis, and its therapeutic effect is remarkable.
Technical scheme of the present invention is:
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 3-15, Herba Artemisiae Scopariae 20-40, Radix Salviae Miltiorrhizae 5-20, Herba Menthae 2-7, Caulis Akebiae 2-10, Rhizoma Coptidis 2-7, Radix Et Rhizoma Rhei 5-15, Fructus Gardeniae 5-15, Rhizoma Alismatis 5-15, Radix Platycodonis 2-10, Herba Houttuyniae 20-40, Radix Aucklandiae 2-10, Herba Patriniae 20-40, Radix Clematidis 20-40, Herba Lysimachiae 20-40, Radix Isatidis 20-40, Radix Gentianae 20-40, Herba Plantaginis 20-40, Fructus Jujubae 15-35.
Preferred weight part of medicine material of the present invention is: Pericarpium Citri Reticulatae 6-12, Herba Artemisiae Scopariae 25-35, Radix Salviae Miltiorrhizae 8-16, Herba Menthae 3-6, Caulis Akebiae 4-8, Rhizoma Coptidis 3-6, Radix Et Rhizoma Rhei 8-12, Fructus Gardeniae 8-12, Rhizoma Alismatis 8-12, Radix Platycodonis 4-8, Herba Houttuyniae 25-35, Radix Aucklandiae 4-8, Herba Patriniae 25-35, Radix Clematidis 25-35, Herba Lysimachiae 25-35, Radix Isatidis 25-35, Radix Gentianae 25-35, Herba Plantaginis 25-35, Fructus Jujubae 20-30.
Optimum weight part of medicine material of the present invention is: Pericarpium Citri Reticulatae 9, Herba Artemisiae Scopariae 30, Radix Salviae Miltiorrhizae 12, Herba Menthae 4.5, Caulis Akebiae 6, Rhizoma Coptidis 4.5, Radix Et Rhizoma Rhei 10, Fructus Gardeniae 10, Rhizoma Alismatis 10, Radix Platycodonis 6, Herba Houttuyniae 30, the Radix Aucklandiae 6, Herba Patriniae 30, Radix Clematidis 30, Herba Lysimachiae 30, Radix Isatidis 30, Radix Gentianae 30, Herba Plantaginis 30, Fructus Jujubae 25.
Herba Houttuyniae in we, Herba Patriniae, Herba Lysimachiae, Radix Isatidis, Radix Gentianae, Herba Plantaginis, Fructus Gardeniae, Radix Et Rhizoma Rhei, Rhizoma Coptidis, according to modern pharmacological research, they all have antiinflammatory, antivirus action, wherein: Herba Lysimachiae clearing heat for detumescence, dehumidifying jaundice eliminating; Radix Isatidis fever, detoxicating and treating jaundice; The Radix Gentianae liver heat removing gallbladder-heat heresy subcutaneous ulcer of harnessing the Yellow River; Herba Plantaginis clearing away heat-damp and promoting diuresis; Herba Houttuyniae heat-clearing and toxic substances removing; Herba Patriniae clearing heat for detumescence row become silted up; The Fructus Gardeniae heat clearing away Huang of dispelling; Radix Et Rhizoma Rhei tonneau defecation, pushes away Chen Zhixin; The Rhizoma Coptidis clearing away liver-fire subcutaneous ulcer of harnessing the Yellow River; Herba Artemisiae Scopariae dampness removing jaundice eliminating; Rhizoma Alismatis eliminating damp-heat; Caulis Akebiae diuresis jaundice eliminating; The Radix Salviae Miltiorrhizae Huang of dispelling of invigorating blood circulation, helps metabolism; Herba Menthae depressed liver-energy dispersing and QI regulating; Pericarpium Citri Reticulatae, Radix Aucklandiae spleen invigorating is regulated the flow of vital energy; Radix Platycodonis a surname venting QI-blood, medicine carrying floating; Fructus Jujubae is fostered taste healthy energy, in case the cold and cool fraud of medicine; The sick institute of the through Liver Channel of vinegar (15-30ml) priming.Clinical in insufficiency of the spleen, deficiency of the kidney, the deficiency of vital energy, blood deficiency, the situations such as cold and heat take the circumstances into consideration to add taste.
In the present invention, each medicine complements each other, and for treatment hepatitis, has remarkable result, and without obvious toxic-side effects.
The present invention treats icterohepatitis, and viral hepatitis is all effective, the bilirubin that hepatitis is caused, and transaminase, the indexs such as two double, DNA undesired has remarkable result.
Icterohepatitis is exactly that hepatocyte is destroyed, hepatic tissue destroys reconstruct, biliary ductuli blocks because hepatitis virus makes, cause conjugated bilirubin and unconjugated bilirubin in blood all to increase, the symptom that caused skin, mucosa and eyeball sclera etc. partly turn to be yellow, total bilirubin normal value is between 3.4～17.1 μ mol/L, and 17.1-34.2 μ mol/L can be considered latent jaundice; 34.2-170 be slight jaundice between μ mol/L; 170-340 μ mol/L is moderate jaundice; Being greater than 340 μ mol/L is severe jaundice.
Viral hepatitis is to be caused by several different Hepadna Virus (hepatitis virus), at present fixed have five types of A type, B-mode, the third type, fourth type and hepatitis E, wherein A type and hepatitis E main manifestations are acute hepatitis, B-mode, the third type, hepatitis D can be the performance of acute hepatitis or chronic hepatitis, and have the possibility that develops into liver cirrhosis and hepatocarcinoma.
Transaminase is requisite in body metabolism process " catalyst ", is mainly present in hepatocyte.When hepatocyte be inflamed, poisoning etc., while causing hepatocyte impaired, transaminase just can be discharged in blood, and serum transaminase is raise.Conventionally, in health check-up, the main transaminase's index checking is alanine aminotransferase (ALT), and alanine aminotransferase index is normal between 0-40, and 1% liver cell infringement can make the concentration of glutamate pyruvate transaminase index in blood increase by 1 times.Therefore, whether gpt level can monitor more sensitively liver and suffer damage.
Hepatitis B virus index comprises five, claims again five indexes of hepatitis b, is the detection methods that the most effectively judges whether to infect hepatitis B virus, is also the severity extent that tentatively judges hepatitis B patient, communicable size etc.; Hepatitis B virus index is the Serum Indexes that has judged whether to infect hepatitis B virus, also can judge in body, whether to contain hbv antibody and hbv antibody titre is how many simultaneously, by Hepatitis B virus, is checked also and can be distinguished hepatitis B great three positive, small three positive.Hepatitis B virus is that the most frequently used hepatitis B virus of current domestic hospitals (HBV) infects detection blood serum designated object.Hepatitis B virus immune is learned 3 pairs altogether of labellings, i.e. surface antigen (HBsAg) and surface antibody (anti-HBs or HBsAb), e antigen (HBeAg) and e antibody (anti-HBe or HBeAb), cAg (HBcAg) and core antibody (anti-HBc or HBcAb).Hepatitis B virus index analysis result is as follows:
Hepatitis B surface antigen (HBsAg) normal value is 0.5ng/ml, exceeds this value hepatitis B virus and is positive, and also represents to check and has all infected hepatitis B virus.Surpass outside range of normal value, be worth highlyer, expression viral load is more.
Hepatitis B surface antibody (HBsAb) is a kind of antibody of protectiveness, and normal value is 10miu/ml, if body inner surface antibody titer more than 10, just can effectively prevent hepatitis B virus invasion.
Liver e antigen (HBeAg) normal value is 0.5PEI U/ml, clinically hepatitis B virus e antigen index, this judgement patient's virus replication situation and infection power.
Hepatitis B e antibody (HBeAb) normal value is 0--0.2PEI U/ml, if hepatitis B virus e antigen is positive, is the hepatitis B sign that sb.'s illness took a favorable turn, and patient body inner virus copies and slows down, infectiousness a little less than.
This index of cAg (HBcAg) does not have too large meaning clinically, only represents that examiner once infected or is infecting now hepatitis B virus.
Hepatitis B virus DNA (deoxyribonucleic acid) is HBV-DNA, and hepatitis B virus is a kind of dsdna segment virus, and the hereditary material that is to say it is DNA, and it is loaded with viral all hereditary information, and hepatitis B virus just can copy, breeds, produce offspring by it.Detecting HBV-DNA is that judgement hepatitis B virus has or not " the golden index " copying, HBVDNA normal value is 3 powers of < 10, HBV-DNA is that hepatitis B virus infection is the most direct, the index that high specificity and susceptiveness are high, the positive prompting of HBV-DNA hepatitis B virus copies and can infect, and HBVDNA concentration is higher shows that virus replication is more active.
Usage and dosage of the present invention: every dose of decocting twice, to divide and take for three times, every day, potion, avoided greasy pungent thing, 15 dose of one course for the treatment of, serve on three courses for the treatment of, drank 15-30ml vinegar as guiding drug before taking, and vinegar can be by guiding drug to liver place, and therapeutic effect is better.
The specific embodiment
Embodiment 1
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 3 g, Herba Artemisiae Scopariae 20g, Radix Salviae Miltiorrhizae 5g, Herba Menthae 2g, Caulis Akebiae 2g, Rhizoma Coptidis 2g, Radix Et Rhizoma Rhei 5g, Fructus Gardeniae 5g, Rhizoma Alismatis 5g, Radix Platycodonis 2g, Herba Houttuyniae 20g, Radix Aucklandiae 2g, Herba Patriniae 20g, Radix Clematidis 20g, Herba Lysimachiae 20g, Radix Isatidis 20g, Radix Gentianae 20g, Herba Plantaginis 20g, Fructus Jujubae 35g.
Embodiment 2
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 15g, Herba Artemisiae Scopariae 40g, Radix Salviae Miltiorrhizae 20g, Herba Menthae 7g, Caulis Akebiae 10g, Rhizoma Coptidis 7g, Radix Et Rhizoma Rhei 15g, Fructus Gardeniae 15g, Rhizoma Alismatis 15g, Radix Platycodonis 10g, Herba Houttuyniae 40g, Radix Aucklandiae 10g, Herba Patriniae 40g, Radix Clematidis 40g, Herba Lysimachiae 40g, Radix Isatidis 40g, Radix Gentianae 40g, Herba Plantaginis 40g, Fructus Jujubae 15g.
Embodiment 3
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 9 g, Herba Artemisiae Scopariae 30g, Radix Salviae Miltiorrhizae 12g, Herba Menthae 4.5g, Caulis Akebiae 6g, Rhizoma Coptidis 4.5g, Radix Et Rhizoma Rhei 10g, Fructus Gardeniae 10g, Rhizoma Alismatis 10g, Radix Platycodonis 6g, Herba Houttuyniae 30g, Radix Aucklandiae 6g, Herba Patriniae 30g, Radix Clematidis 30g, Herba Lysimachiae 30g, Radix Isatidis 30g, Radix Gentianae 30g, Herba Plantaginis 30g, Fructus Jujubae 25g.
Embodiment 4
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 6g, Herba Artemisiae Scopariae 25g, Radix Salviae Miltiorrhizae 8g, Herba Menthae 3g, Caulis Akebiae 4g, Rhizoma Coptidis 3g, Radix Et Rhizoma Rhei 8g, Fructus Gardeniae 8g, Rhizoma Alismatis 8g, Radix Platycodonis 4g, Herba Houttuyniae 25g, Radix Aucklandiae 4g, Herba Patriniae 25g, Radix Clematidis 25g, Herba Lysimachiae 25g, Radix Isatidis 25g, Radix Gentianae 25g, Herba Plantaginis 25g, Fructus Jujubae 30g.
Embodiment 5
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 12g, Herba Artemisiae Scopariae 35g, Radix Salviae Miltiorrhizae 16g, Herba Menthae 6g, Caulis Akebiae 8g, Rhizoma Coptidis 6g, Radix Et Rhizoma Rhei 12g, Fructus Gardeniae 12g, Rhizoma Alismatis 12g, Radix Platycodonis 8g, Herba Houttuyniae 35g, Radix Aucklandiae 8g, Herba Patriniae 35g, Radix Clematidis 35g, Herba Lysimachiae 35g, Radix Isatidis 35g, Radix Gentianae 35 g, Herba Plantaginis 35g, Fructus Jujubae 20g.
Embodiment 6
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 8g, Herba Artemisiae Scopariae 27g, Radix Salviae Miltiorrhizae 10g, Herba Menthae 4g, Caulis Akebiae 5g, Rhizoma Coptidis 5g, Radix Et Rhizoma Rhei 9g, Fructus Gardeniae 9g, Rhizoma Alismatis 9g, Radix Platycodonis 5g, Herba Houttuyniae 27g, Radix Aucklandiae 5g, Herba Patriniae 27g, Radix Clematidis 27g, Herba Lysimachiae 27g, Radix Isatidis 27g, Radix Gentianae 27g, Herba Plantaginis 27g, Fructus Jujubae 23g.
Embodiment 7
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 10g, Herba Artemisiae Scopariae 32g, Radix Salviae Miltiorrhizae 14g, Herba Menthae 5g, Caulis Akebiae 7g, Rhizoma Coptidis 5g, Radix Et Rhizoma Rhei 11g, Fructus Gardeniae 11g, Rhizoma Alismatis 11g, Radix Platycodonis 7g, Herba Houttuyniae 32g, Radix Aucklandiae 7g, Herba Patriniae 32g, Radix Clematidis 32g, Herba Lysimachiae 32g, Radix Isatidis 32g, Radix Gentianae 32g, Herba Plantaginis 32g, Fructus Jujubae 27g.
Embodiment 8
Treat a Chinese medicine for hepatitis, it is comprised of the raw material of following weight portion: Pericarpium Citri Reticulatae 4g, Herba Artemisiae Scopariae 22g, Radix Salviae Miltiorrhizae 6g, Herba Menthae 2g, Caulis Akebiae 3g, Rhizoma Coptidis 2g, Radix Et Rhizoma Rhei 6g, Fructus Gardeniae 6g, Rhizoma Alismatis 6g, Radix Platycodonis 3g, Herba Houttuyniae 22g, Radix Aucklandiae 3g, Herba Patriniae 22g, Radix Clematidis 22g, Herba Lysimachiae 22g, Radix Isatidis 22g, Radix Gentianae 22g, Herba Plantaginis 22g, Fructus Jujubae 17g.
Medicine of the present invention also can be prepared into powder, capsule, tablet or oral liquid according to a conventional method.
The situation that 30 routine patients are carried out to clinical observation: male's 20 examples, women's 10 examples, icterohepatitis 18 examples wherein, 15 examples are cured, hepatitis B 12 examples, wherein 8 routine liver function recoveries are normal.
Model case
Wang, man, 26 years old, people from Anyang County, within 5 months, when large, certain city infectious hospital is diagnosed as icterohepatitis, and its age of gallbladder is little, is in a bad way, hospital refuses continual cure, is forced to leave hospital, and facial withered and yellow at that time, psychosis is good, anorexia, its chemical examination total bilirubin 170-340 μ mol/L, alanine aminotransferase index 65, after take medicine of the present invention, while taking, with brown sugar, slowly feed the medical treatment recovery from illness through month, chemical examination total bilirubin, 15 μ mol/L, alanine aminotransferase index 32.
Poplar, man, 38 years old, Anyang County Enterprise Staff, Jing Mou city infectious hospital was diagnosed as hepatitis B, through two months hospitalization, spray interferon etc., liver function still can not be recovered normally, and six inspections of hepatitis B are still great three positive, DNA numerical value is 1500, DNA numerical value is remained high, after take medicine of the present invention, take after 50 doses, great three positive changes into small three positive, and liver function DNA value is 800.
Zhang, man, 4 years old, unexpected yellowish body, yellowish fur on the tongue, yellow urine, anorexia, certain county hospital is diagnosed as icterohepatitis, after hospitalization first quarter moon, slightly alleviates, after leave hospital and come here medical, its laboratory test report jaundice (total bilirubin) index is more than 180, whole body tool is yellow, become thin, with using medicine of the present invention, damp-excreting anti-icteric medicinal thing increases the weight of, potion divides repeatedly to be taken on the 2nd, and after two weeks, the every laboratory test report of liver function is normal, and total bilirubin matter index is 14.
Liu, female, 49 years old, cement plant, Anyang County family members, readme when medical: anorexia, the whole body is unable.To certain county hospital inspection, be diagnosed as hepatitis B, two double one three five positives.Through a month remaining treatment, again check two double, numerical value does not have much changes, change Chinese traditional treatment into, 30 multi-agents that take traditional Chinese medicine again, result of laboratory test two does not change for double yet, come here medical, after take medicine of the present invention, serve on 35 doses, again chemically examine two double (six of hepatitis B) and all turn out cloudy, patient's whole body, without any pathological reaction, is cured drug withdrawal substantially.
Wang, man, 6 years old, people from Anyang County, certain county hospital is diagnosed as icterohepatitis, and hospitalization was left hospital after one month, but it shows anorexia, and colour of the tongue is still turned to be yellow, come here medical, icteric index while leaving hospital (total bilirubin) 70, after take medicine of the present invention, take 20 doses of the present invention, liver function is normal, icteric index (total bilirubin) is 15.5, recovery from illness drug withdrawal.
Claims (3)
1. a Chinese medicine for the treatment of hepatitis, is characterized in that: it is to be made by the raw material of following weight portion: Pericarpium Citri Reticulatae 3-15, Herba Artemisiae Scopariae 20-40, Radix Salviae Miltiorrhizae 5-20, Herba Menthae 2-7, Caulis Akebiae 2-10, Rhizoma Coptidis 2-7, Radix Et Rhizoma Rhei 5-15, Fructus Gardeniae 5-15, Rhizoma Alismatis 5-15, Radix Platycodonis 2-10, Herba Houttuyniae 20-40, Radix Aucklandiae 2-10, Herba Patriniae 20-40, Radix Clematidis 20-40, Herba Lysimachiae 20-40, Radix Isatidis 20-40, Radix Gentianae 20-40, Herba Plantaginis 20-40, Fructus Jujubae 15-35.
2. the Chinese medicine for the treatment of hepatitis according to claim 1, is characterized in that, it is to be made by the raw material of following weight portion: Pericarpium Citri Reticulatae 6-12, Herba Artemisiae Scopariae 25-35, Radix Salviae Miltiorrhizae 8-16, Herba Menthae 3-6, Caulis Akebiae 4-8, Rhizoma Coptidis 3-6, Radix Et Rhizoma Rhei 8-12, Fructus Gardeniae 8-12, Rhizoma Alismatis 8-12, Radix Platycodonis 4-8, Herba Houttuyniae 25-35, Radix Aucklandiae 4-8, Herba Patriniae 25-35, Radix Clematidis 25-35, Herba Lysimachiae 25-35, Radix Isatidis 25-35, Radix Gentianae 25-35, Herba Plantaginis 25-35, Fructus Jujubae 20-30.
3. the Chinese medicine for the treatment of hepatitis according to claim 2, is characterized in that, it is to be made by the raw material of following weight portion: Pericarpium Citri Reticulatae 9, Herba Artemisiae Scopariae 30, Radix Salviae Miltiorrhizae 12, Herba Menthae 4.5, Caulis Akebiae 6, Rhizoma Coptidis 4.5, Radix Et Rhizoma Rhei 10, Fructus Gardeniae 10, Rhizoma Alismatis 10, Radix Platycodonis 6, Herba Houttuyniae 30, the Radix Aucklandiae 6, Herba Patriniae 30, Radix Clematidis 30, Herba Lysimachiae 30, Radix Isatidis 30, Radix Gentianae 30, Herba Plantaginis 30, Fructus Jujubae 25.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310099127.9A CN104069283A (en) | 2013-03-26 | 2013-03-26 | Traditional Chinese medicine for treating hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310099127.9A CN104069283A (en) | 2013-03-26 | 2013-03-26 | Traditional Chinese medicine for treating hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104069283A true CN104069283A (en) | 2014-10-01 |
Family
ID=51591149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310099127.9A Pending CN104069283A (en) | 2013-03-26 | 2013-03-26 | Traditional Chinese medicine for treating hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104069283A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112773875A (en) * | 2021-01-29 | 2021-05-11 | 王启强 | Liver-protecting pill and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152542A (en) * | 2007-09-28 | 2008-04-02 | 孙长松 | Traditional Chinese medicine for treating cholestatic hepatitis |
| CN101744954A (en) * | 2009-12-29 | 2010-06-23 | 谭友民 | Medicine for internally treating icteric hepatitis |
-
2013
- 2013-03-26 CN CN201310099127.9A patent/CN104069283A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152542A (en) * | 2007-09-28 | 2008-04-02 | 孙长松 | Traditional Chinese medicine for treating cholestatic hepatitis |
| CN101744954A (en) * | 2009-12-29 | 2010-06-23 | 谭友民 | Medicine for internally treating icteric hepatitis |
Non-Patent Citations (2)
| Title |
|---|
| 本书编委会主编: "《中国现代保健药物食物大全》", 31 August 2007 * |
| 马龙: "中西医结合治疗重型肝炎38例", 《中医研究》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112773875A (en) * | 2021-01-29 | 2021-05-11 | 王启强 | Liver-protecting pill and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755594B (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN103040960A (en) | Traditional Chinese medicine formula for treating high blood pressure | |
| CN104383055A (en) | Drug for treating end-stage liver diseases caused by chronic hepatitis B and preparation method of drug | |
| CN104707108A (en) | Traditional Chinese medicine composition for treating chronic virulent hepatitis b and preparation method thereof | |
| CN102178788B (en) | Chinese medicinal composition for reducing transaminase and jaundice and preparation method thereof | |
| CN1329047C (en) | Chinese medicinal composition for treating acute icterohepatitis | |
| CN104288594B (en) | A kind ofly treat Chinese medicine preparation of chronic kidney disease syndrome of deficiency of both qi and yin and preparation method thereof | |
| CN101745077A (en) | Compound Chinese medicinal preparation for treating fatty liver, alcoholic hepatitis and complications | |
| CN103599495A (en) | Chinese medicinal composition for treatment of hepatitis B | |
| CN101869687B (en) | Medicament for treating fatty liver and alcohol liver, and reducing blood lipid and aminotransferase | |
| CN104069283A (en) | Traditional Chinese medicine for treating hepatitis | |
| CN103251876B (en) | Traditional Chinese medicine composition used for treating chronic liver diseases | |
| CN116139237A (en) | A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application | |
| CN103211961A (en) | Traditional Chinese medicine composition for treating chronic renal insufficiency | |
| CN103830337B (en) | Chinese medicinal composition for treating chronic alcoholic toxic liver disease | |
| CN105169215A (en) | Traditional Chinese medicine composition for treating alcoholic fatty liver | |
| CN102895420B (en) | Chinese medicinal composition for treating hepatic diseases | |
| CN104547070A (en) | Medical composition resistant to hepatitis b viruses as well as preparation method and application of medical composition | |
| CN106109731A (en) | A kind of Chinese medicine composition treating chronic hepatopathy and preparation method thereof | |
| CN104491574B (en) | A kind of Chinese medicine preparation for being used to recuperate under medical treatment chronic hepatitis B | |
| CN103505500B (en) | A kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof | |
| CN103272183B (en) | Traditional Chinese medicine for treating hepatitis B induced cirrhosis | |
| CN103301197B (en) | Traditional Chinese medicinal preparation for treating chronic hepatitis and initial cirrhosis, and preparation method of traditional Chinese medicinal preparation | |
| CN102406906A (en) | Traditional Chinese medicine composition for treating acute hepatitis B | |
| CN108057097A (en) | A kind of Chinese herb drugs prescription for treating proteinuria of renal disease and preparation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141001 |
|
| RJ01 | Rejection of invention patent application after publication |